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Introduction
Indigenous populations often have poorer health than 
their respective majority reference populations [1], 
and recent reviews have indicated poorer cardiovascu-
lar health in Inuit populations and other indigenous 
populations in North America [2–4]. Population 
health is sculptured by many factors: level of educa-
tion, wealth, environmental quality and protection, 
diet, behaviour traits such as physical activity and 
smoking, occupational and domestic stresses and 
genetics. Varying exposures to such factors over time 
can generate ethnic differences in health [5].
The Sami are an indigenous people whose tradi-
tional settlement area, Sápmi, stretches from the 
Kola Peninsula in the north to Engerdal and Idre in 
the south of Norway and Sweden, respectively [6]. 
Finnmark is the northernmost county in Norway and 
the region most influenced by Sami language and 
culture [6]. The Kven are descendants of Finnish-
speaking settlers who emigrated from Sweden and 
Finland to the northern parts of Norway in the 1700s 
and 1800s [7].
In 1974–1975, a cardiovascular risk score among 
Sami and Kven/Finnish men aged 35–49 years in 
Finnmark was about 40% higher than that among 
Norwegian men [8]. The score only included systolic 
blood pressure, serum total cholesterol and smoking 
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habits. however, later studies restricted to Finnmark 
county in the period 1974–1989 [9–12] and the 
SAMINOR 1 Survey from 2003–2004 [13] also 
including the southern regions of Sápmi showed 
none or only minor differences in the distribution of 
cardiovascular risk factors and in the burden of car-
diovascular disease (cVD) between Sami and non-
Sami populations in Norway. In terms of differences 
in cVD mortality between these ethnic groups, there 
have been conflicting results [14,15]. Furthermore, 
in Northern Norway, risk-factor levels and cVD 
mortality have declined over the last decades [16]. 
Whether this decline has been the same in Sami and 
non-Sami populations is unknown. hence, updated 
knowledge concerning the distribution of cVD risk 
factors and a comprehensive cVD risk assessment of 
the Sami and non-Sami populations settled in Sápmi 
is needed.
cVD is multifactorial. Thus, guidelines for pre-
vention recommend assessing the impact of several 
risk factors simultaneously [17]. The NORRISK 2 
model is a cardiovascular risk model based on 
Norwegian data. It estimates the 10-year risk of fatal 
or non-fatal acute myocardial infarction (AMI) or 
cerebral stroke (cS) by combining information from 
several risk factors [18]. using this model and data 
from the second survey of the Population-based 
Study on health and living conditions in Regions 
with Sami and Norwegian Populations (the 
SAMINOR 2 clinical Survey), the primary objective 
of the present study was to compare the distribution 
of risk factors included in the NORRISK 2 model 
and the estimated 10-year risk of AMI or cS in Sami 
and non-Sami populations. Furthermore, to give a 
comprehensive cardiovascular risk profile to Sami 
and non-Sami populations, we also present the distri-
bution of other established risk factors and education 
attainment. The 10-year risk for AMI or cS has not 
previously been computed and compared for Sami 
and non-Sami populations.
Methods
The Population-based Study on health and living 
conditions in Regions with Sami and Norwegian 
Populations – the SAMINOR Study – is run by the 
centre for Sami health Research at uiT – The Arctic 
university of Norway. The present analyses are based 
on cross-sectional data from the second survey, the 
SAMINOR 2 clinical Survey (hereafter referred to 
as SAMINOR 2), conducted in 2012–2014. 
Invitation to SAMINOR 2 included all inhabitants 
(n=12,455) aged 40–79 years residing in the munici-
palities of Evenes in Nordland county; Skånland, 
Kåfjord, Storfjord and lyngen in Troms county; and 
Karasjok, Kautokeino, Porsanger, Tana and Nesseby 
in Finnmark county. In total, 6004 inhabitants 
accepted. The overall response rate was 48.2% (i.e. 
45.8% men and 54.2% women) and varied from 
41% in Evenes to 56% in Kautokeino. The partici-
pants completed a self-administered questionnaire 
that was mailed with the invitation letter and returned 
at the clinical examination. Participants aged 40–69 
years completed an eight-page questionnaire; those 
aged 70–79 years completed a four-page question-
naire, with fewer questions and larger fonts. 
Questionnaires were prepared in Norwegian and 
translated into Northern Sami. Both the Sami and 
the Norwegian versions of the questionnaire were 
distributed to participants in Kautokeino, Karasjok, 
Nesseby and Tana, and the Sami version was availa-
ble upon request to participants in Kåfjord, Storfjord, 
Porsanger and lyngen. Invitees in Skånland and 
Evenes received the Norwegian questionnaire only. 
The SAMINOR Study was accredited by the 
Norwegian Data Inspectorate and approved by the 
Regional committee for Medical and health 
Research Ethics. The committee also approved this 
study, for which all participants gave written informed 
consent.
Clinical examination and blood-sample 
collection
Waist circumference was measured at the umbilicus 
with the participant standing, and abdominal obesity 
was determined by using the thresholds >102 cm 
and >88 cm for men and women, respectively. At 
least 15 minutes after participant arrival, blood pres-
sure was measured with an automatic device 
(cAREScAPE™ V100 monitor), with the partici-
pants in a seated position with their arms resting at 
heart level. Following a two-minute rest, three meas-
urements were taken at one-minute intervals. The 
average of the last two measurements was used in the 
statistical analysis.
Non-fasting blood samples were collected with 
participants in a seated position. Tubes with antico-
agulant were used for glycated haemoglobin 
(hbA1c) measurements conducted on-site within 
15 minutes of blood collection using DcA Vantage™ 
(Siemens Medical Solutions Diagnostics, Tarrytown, 
NY), which uses an agglutination inhibition immu-
noassay method. Tubes for serum samples were cen-
trifuged within two hours of blood collection. Serum 
was separated and stored at −20°c, transported for 
further storage at –70°c and later used to analyse 
high-density lipoprotein (hDl) cholesterol, triglyc-
erides and total cholesterol at the university hospital 
of North Norway using an enzymatic colorimetric 
640  S.R.A. Siri et al.
test run with cobas 8000B (Roche Diagnostics 
Gmbh, Mannheim, Germany). Thresholds for tri-
glycerides and hbA1c were taken from European 
[17] and World health Organization guidelines [19], 
respectively.
Questionnaire
Ethnicity was ascertained by the questions: ‘What 
language(s) do/did you, your parents and your grand-
parents use at home?’, ‘What is your, your father’s 
and your mother’s ethnic background?’ and ‘What 
ethnicity do you consider yourself to be?’ On all 
items, the response options were ‘Norwegian’, ‘Sami’, 
‘Kven’ and ‘other’. The questions were answered sep-
arately for each relative (11 questions in total), and 
multiple answers were allowed. Participants were 
defined as Sami if they considered themselves to be 
Sami or reported a Sami ethnic background and at 
least one of their grandparents, parents or they them-
selves spoke a Sami language at home. All others 
were categorised as non-Sami.
We identified current smokers and non-smokers 
from the questions: ‘have you ever smoked daily?’ (yes/
no) and ‘Are you currently a daily smoker?’ (yes/no). 
Previous smokers were categorised as non-smokers.
Anti-hypertensive treatment was ascertained from 
the question: ‘Are you taking medication for high 
blood pressure?’ The response options were ‘yes, cur-
rently’, ‘in the past, but not currently’ and ‘no’. 
Participants reporting former use were merged with 
non-users, and missing values were ad hoc imputed 
as non-users.
Both questionnaire information and hbA1c meas-
urements were applied to identify participants with 
diabetes mellitus. The question was: ‘have you ever 
been diagnosed with diabetes (high blood sugar)?’ 
(yes/no). Missing values were classified as ‘no’. In 
addition, all participants with hbA1c values ≥6.5% 
(48 mmol/mol) were classified as having diabetes mel-
litus, regardless of their reply on the questionnaire.
Physical activity was measured by asking: ‘Please 
indicate your levels of physical activity at the ages of 
14, 30 and at your current age, on a scale from 1 to 
10. “Physical activity” includes household chores 
and professional activities, as well as regular exercise 
and other physical activity, such as walking/hiking. 
Please mark (with an ‘X’) below the number that 
most accurately denotes your physical activity levels’. 
In this study, we used physical activity at current age, 
an instrument validated in middle-aged women liv-
ing in Tromsø, Norway [20]. We recoded the 10-level 
physical activity scale into three categories: low (lev-
els 1–3), moderate (levels 4–7) and high physical 
activity (levels 8–10).
Years of education was measured with the ques-
tion: ‘how many years of education have you com-
pleted? (Include any and all years in which you 
attended school or studied)’. We categorised this item 
into three levels: 0–9 years, 10–12 years and ≥13 
years, which roughly corresponds to compulsory pri-
mary and lower secondary school, upper secondary 
school and higher education, respectively.
The NORRISK 2 model
The NORRISK 2 model is validated and intended to 
be used in primary prevention of cVD in the 
Norwegian population aged 40–79 years [18]. The 
model is used to estimate the 10-year risk (%) of hos-
pitalisation with AMI (International classification of 
Diseases [IcD-10] codes I21–22) as main or second-
ary diagnosis, death from ischaemic heart diseases 
(IcD-10 codes I20–25) as the underlying cause, or 
hospitalisation with cS (IcD-10 codes I60–61 and 
I63–64 except I63.6) as main or secondary diagnosis 
or death from cS as underlying cause [18]. The 
10-year risk estimations are based on sex, age, total 
cholesterol, hDl-cholesterol, systolic blood pres-
sure, smoking habits, anti-hypertensive treatment 
and family history of premature coronary heart dis-
ease [18]. All but family history of premature coro-
nary heart disease were included in SAMINOR 2. In 
the model development, Selmer et al. treated death 
from other causes as competing risk. We used the 
age-specific, high-risk thresholds suggested by 
Selmer et  al. [18] to identify individuals at high 
10-year risk of fatal or non-fatal AMI or cS events 
who should be offered pharmacological treatment: 
≥5% in the age group 45–54, ≥10% in the age group 
55–64 and ≥15% in the age group 65–74 years. For 
those aged 40–44 and 75–79 years included in our 
study, we used the high risk threshold ≥5% and 
≥15%, respectively.
Statistical analyses
Statistical analyses were performed using Stata v14.0 
(Statacorp, college Station, TX). Ethnic differences 
in characteristics and age-specific cardiovascular 
risks were tested by two-sample t-tests with equal 
variance for continuous variables and Pearson’s chi-
square test (Tables I and II) and Fisher’s exact test 
(Tables III and IV) for categorical variables. Test of 
trends across ordered groups (Tables I and II) was 
done with Wilcoxon’s rank-sum test. Age standardi-
sation of means and proportions was done separately 
in men and women using the direct method and hav-
ing the sex-specific invited SAMINOR 2 sample in 
five-year age groups as the standard population. 
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comparisons of age-standardised means and pro-
portions were done with a two-sample t-test with 
equal variance and a two-sample test for propor-
tions, respectively, using the age-standardised esti-
mates of means, proportions and standard deviations. 
We considered p-values <0.05 to be statistically 
significant.
In sensitivity analyses, three ethnic categories were 
compared with regard to mean risk scores and pro-
portions at high risk: (1) those who reported ‘Sami’ 
on all 11 questions on ethnicity, (2) those who 
reported ‘Sami’ on at least one question and (3) 
those not reporting ‘Sami’ on any of the questions. 
We assessed whether region of residence modified 
mean risk scores and proportions at high risk (using 
the original ethnic categorisation) by merging munic-
ipalities that may be perceived as similar in terms of 
number of Sami inhabitants, Sami language users 
and geographical location: (1) Kautokeino and 
Karasjok; (2) Nesseby, Tana and Porsanger; and (3) 
Skånland, Evenes, Storfjord, lyngen and Kåfjord. 
Additionally, in a separate set of analyses, we excluded 
participants on anti-hypertensive treatment (n=1382) 
to explore whether there were ethnic differences in 
non-users of anti-hypertensive medication.
Results
Of the 6004 SAMINOR 2 participants, 21 did not 
answer the questionnaire, 75 did not answer the 
questions on ethnicity, 26 had missing cholesterol 
values, three had missing systolic blood pressure, 193 
reported angina pectoris, 244 reported AMI and 124 
had missing information on smoking habits and were 
excluded. Thus, our analyses included 5318 individ-
uals (44.1% of the sample were men and 40.8% were 
Sami), representing 42.7% of the invited sample.
In men, statistically significant differences were 
found in mean total cholesterol, the distribution of 
hDl-cholesterol and triglycerides, mean diastolic 
blood pressure, hbA1c, proportions with diabetes 
mellitus, mean waist circumference and the level of 
Table I. unadjusted sample characteristics of non-Sami and Sami men (n=2346): The SAMINOR 2 clinical Survey (2012–2014).
Variables Non-Sami, n = 1372 Sami, n = 974 p-value
Age (years), mean (SD) 59.4 (10.2) 58.8 (10.1) 0.11
 40–54 years, % (n) 32.9 (451) 36.3 (353) 0.03
 55–64 years, % (n) 31.4 (431) 32.4 (316)  
 65–79 years, % (n) 35.7 (490) 31.3 (305)  
Total cholesterol (mmol/l), mean (SD) 5.42 (1.0) 5.52 (1.1) 0.03
Total cholesterol >5.0 mmol/l, % (n) 67.6 (928) 69.7 (679) 0.29
hDl-cholesterol (mmol/l), mean (SD) 1.29 (0.4) 1.24 (0.4) <0.001
hDl-cholesterol <1.0 mmol/l, % (n) 17.9 (246) 21.6 (210) 0.03
Triglycerides (mmol/l), mean (SD) 1.80 (1.1) 1.94 (1.1) 0.002
Triglycerides >1.7 mmol/l, % (n) 44.1 (605) 51.2 (499) 0.001
Systolic blood pressure (mmhg), mean (SD) 134.9 (17.2) 134.3 (18.1) 0.39
Systolic blood pressure ≥140 mmhg, % (n) 34.4 (472) 33.8 (329) 0.75
Diastolic blood pressure (mmhg), mean (SD) 78.1 (9.4) 77.3 (9.9) 0.04
Diastolic blood pressure ≥90 mmhg, % (n) 11.0 (151) 11.4 (111) 0.77
Anti-hypertensive treatment (yes), % (n) 26.7 (366) 23.4 (228) 0.07
current smoking (yes), % (n) 16.0 (220) 19.1 (186) 0.05
hbA1ca (%), mean (SD) 5.69 (0.6) 5.79 (0.8) <0.001
Diabetes mellitusb (yes), % (n) 8.3 (114) 11.0 (107) 0.03
Waist circumferencec (cm), mean (SD) 100.0 (10.6) 98.5 (10.8) 0.001
Waist circumference >102 cm, % (n) 35.0 (479) 31.8 (309) 0.11
Physical activityd, mean (SD) 5.3 (2.0) 5.2 (2.2) 0.08
 low (1–3), % (n) 19.6 (263) 23.4 (220) 0.43
 Moderate (4–7), % (n) 66.3 (892) 60.6 (569)  
 high (8–10), % (n) 14.1 (190) 16.0 (150)  
Years of educatione, mean (SD) 12.0 (3.6) 11.7 (3.7) 0.14
 0–9 years, % (n) 27.7 (369) 32.3 (302) 0.04
 10–12 years, % (n) 33.1 (441) 31.0 (290)  
 ≥13 years, % (n) 39.2 (524) 36.7 (343)  
aMissing values: non-Sami, n = 3; Sami, n = 3.
bDiabetes mellitus: self-reported diabetes or hbA1c ≥6.5%.
cMissing values: non-Sami, n = 3; Sami, n = 2.
dMissing values: non-Sami, n = 27; Sami, n = 35.
eMissing values: non-Sami, n = 38; Sami, n = 39.
SD: standard deviation.
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education (Table I). compared with non-Sami men, 
Sami men had a more unfavourable distribution 
(except for waist circumference and diastolic blood 
pressure).
In women, Sami had statistically significantly 
lower hDl-cholesterol and physical activity level 
and higher triglycerides and higher proportions with 
waist circumference >88 cm (Table II).
Table II. unadjusted sample characteristics of non-Sami and Sami women (n=2972): The SAMINOR 2 clinical Survey (2012–2014).
Variables Non-Sami, n=1777 Sami, n=1195 p-value
Age (years), mean (SD) 58.6 (10.6) 57.9 (10.2) 0.08
 40–54 years, % (n) 37.0 (657) 37.7 (451) 0.10
 55–64 years, % (n) 30.4 (541) 34.0 (406)  
 65–79 years, % (n) 32.6 (579) 28.3 (338)  
Total cholesterol (mmol/l), mean (SD) 5.59 (1.0) 5.61 (1.1) 0.55
Total cholesterol >5.0 mmol/l, % (n) 71.1 (1264) 72.1 (861) 0.59
hDl-cholesterol (mmol/l), mean (SD) 1.55 (0.5) 1.45 (0.4) <0.001
hDl-cholesterol <1.3 mmol/l, % (n) 25.3 (450) 32.7 (391) <0.001
Triglycerides (mmol/l), mean (SD) 1.53 (0.9) 1.66 (0.9) <0.001
Triglycerides >1.7 mmol/l, % (n) 33.6 (597) 39.7 (475) 0.001
Systolic blood pressure (mmhg), mean (SD) 130.6 (18.3) 129.6 (19.3) 0.14
Systolic blood pressure ≥140 mmhg, % (n) 27.0 (479) 26.5 (317) 0.80
Diastolic blood pressure (mmhg), mean (SD) 72.4 (9.0) 71.8 (9.3) 0.08
Diastolic blood pressure ≥90 mmhg, % (n) 3.6 (64) 3.8 (45) 0.82
Anti-hypertensive treatment (yes), % (n) 26.7 (475) 26.2 (313) 0.75
current smoking (yes), % (n) 20.1 (357) 22.5 (269) 0.11
hbA1ca (%), mean (SD) 5.66 (0.6) 5.71 (0.5) 0.05
Diabetes mellitusb (yes), % (n) 8.3 (148) 10.0 (120) 0.11
Waist circumferencec (cm), mean (SD) 92.7 (12.1) 93.4 (12.0) 0.13
Waist circumference >88 cm, % (n) 61.7 (1093) 66.1 (789) 0.01
Physical activityd,mean (SD) 5.6 (2.1) 5.3 (2.1) <0.001
 low (1–3), % (n) 15.5 (257) 22.8 (261) <0.001
 Moderate (4–7), % (n) 64.8 (1076) 60.7 (696)  
 high (7–10), % (n) 19.7 (328) 16.5 (189)  
Years of educatione,mean (SD) 12.4 (4.0) 12.7 (4.4) 0.09
 0–9 years, % (n) 26.0 (445) 27.8 (316) 0.28
 10–12 years, % (n) 30.3 (517) 23.2 (263)  
 ≥13 years, % (n) 43.7 (747) 49.0 (556)  
aMissing values: non-Sami, n=1; Sami, n=6.
bDiabetes mellitus: self-reported diabetes or hbA1c ≥6.5%.
cMissing values: non-Sami, n=5; Sami, n=2.
dMissing values: non-Sami, n=116; Sami, n=49.
eMissing values: non-Sami, n=68; Sami, n=60.
SD: standard deviation.
Table III. Mean 10-year risk and proportion of participants at high risk of acute myocardial infarction (AMI) or cerebral stroke (cS) in 
non-Sami and Sami men aged 40–79 years, n=2346: The SAMINOR 2 clinical Survey (2012–2014).
Age Non-Sami (n=1372) Sami (n=974)
n n p-value
40–54 years Mean (SD) 451 3.6 (2.6) 353 4.0 (3.1) 0.06
 ≥5% (n) 21.5% (97) 23.2% (82) 0.61
55–64 years Mean (SD) 431 8.8 (4.2) 316 9.5 (5.0) 0.06
 ≥10% (n) 26.7% (115) 36.1% (114) 0.006
65–79 years Mean (SD) 490 18.0 (6.4) 305 18.1 (6.7) 0.81
 ≥15% (n) 63.5% (311) 61.3% (187) 0.55
Total  
crude mean (SE) 1372 10.4 (0.21) 974 10.2 (0.25) 0.55
Age-standardised mean (SE) 1372 9.5 (0.10) 974 9.8 (0.13) 0.05
% with high riska (n) 38.1% (523) 39.3% (383) 0.56
Age-standardised % with high risk 35.6% 37.5% 0.35
aProportions with 10-year risk of AMI or cS ≥5%, ≥10% and ≥15% in age groups 40–54, 55–64 and 65–79 years, respectively.
SD: standard deviation.
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In the total analytical population, disregarding eth-
nicity, the age-standardised mean 10-year risk of AMI 
or cS and the proportion of participants at high risk 
were 9.6% and 36.4%, respectively, for men, and 5.8% 
and 11.6%, respectively, for women (results not shown).
The mean 10-year risk of AMI or cS by age for 
Sami and non-Sami men and women is displayed in 
Figure 1. Overall, there were no ethnic differences in 
the 10-year risk of AMI or cS (Tables III and IV, and 
Figure 1). This was due to only minor ethnic differ-
ences in the distribution of the cardiovascular risk 
factors included in the NORRISK 2 model. however, 
among men aged 55–64 years, more Sami than non-
Sami had a high 10-year risk of AMI or cS (36.1% 
vs. 26.7%; p=0.006). Sami men in this age group had 
a somewhat unfavourable distribution in most of the 
risk factors included in the model (results not shown). 
Additionally, the age-standardised 10-year mean risk 
for non-Sami and Sami men was borderline signifi-
cant (9.5 vs. 9.8; p=0.05).
Overall, the sensitivity analyses did not show 
markedly different results by ethnicity or region of 
residence. Among non-users of anti-hypertensive 
medication, Sami women had lower systolic (125.9 
vs. 127.9 mmhg; p=0.008) and diastolic (71.0 vs. 
71.9 mmhg; p=0.02) blood pressure than non-Sami 
women (results not shown).
Discussion
We observed no overall differences in the 10-year risk 
of AMI or cS, as estimated by the NORRISK 2 
model, between Sami and non-Sami participants. 
This was due to minor ethnic differences in the dis-
tribution of the cardiovascular risk factors included 
in the model. Overall, 36.4% of men and 11.6% of 
women had a high 10-year risk of AMI or cS.
Our results of an overall similar distribution of 
cardiovascular risk factors between Sami and non-
Sami participants agree with previous studies from 
Norway, Sweden and Finland [9-10, 13, 21-25]. 
however, we found a somewhat unfavourable distri-
bution of triglycerides, physical activity (women 
only), waist circumference (women only) and diabe-
tes mellitus (men only) in Sami compared to non-
Sami participants. To what extent ethnic discrepancies 
in these risk factors may contribute to a different risk 
of AMI or cS in Sami relative to non-Sami popula-
tions, is uncertain.
A publication with data from 1974/1975–1989 
found that Sami men in Finnmark had a similar risk 
of AMI to Norwegian men, but indicated a 50% 
increased incidence of cerebrovascular disease [12]. 
In 1970–1998, Sami men and women (based on 
census data) living north of the Arctic circle in 
Norway had higher mortality from cerebrovascular 
diseases, that is, 14% and 28% higher mortality rates 
in men and women, respectively. however, male 
reindeer herders had a lower risk of death from 
ischaemic heart disease than other Sami and non-
Sami populations, and this was also the case, to some 
extent, for cerebrovascular disease [14]. In a follow-
up study from 1977/1978–1992, including men aged 
35–52 years in Finnmark, 67% and 52% lower mor-
tality rates were found for ischaemic heart disease 
and total cVD, respectively, in Sami compared to 
non-Sami men [15].
Among men in Sweden, the overall incidence of 
hospitalisations due to cerebrovascular disease 
was higher in Sami populations but lower in Sami 
Table IV. Mean 10-year risk and proportion of participants at high risk of acute myocardial infarction (AMI) or cerebral stroke (cS) in 
non-Sami and Sami women aged 40–79 years, n=2972: The SAMINOR 2 clinical Survey (2012–2014).
Age Non-Sami (n=1777) Sami (n=1195)
n n p-value
40–54 years Mean (SD) 657 1.3 (1.2) 451 1.4 (1.3) 0.24
 ≥5% (n) 2.3% (15) 2.7% (12) 0.70
55–64 years Mean (SD) 541 5.0 (3.0) 406 4.7 (2.8) 0.27
 ≥10% (n) 5.2% (28) 5.4% (22) 0.88
65–79 years Mean (SD) 579 12.0 (5.4) 338 12.2 (5.3) 0.68
 ≥15% (n) 24.7% (143) 28.1% (95) 0.28
Total
crude mean (SE) 1777 5.9 (0.14) 1195 5.6 (0.16) 0.12
Age-standardised mean (SE) 1777 5.8 (0.07) 1195 5.9 (0.08) 0.44
% with high riska (n) 10.5% (186) 10.8% (129) 0.78
Age-standardised % with high risk 11.0% 12.6% 0.19
aProportions with 10-year risk of AMI or cS ≥5%, ≥10% and ≥15% in age groups 40–54, 55–64 and 65–79 years, respectively.
SD: standard deviation.
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reindeer herders than in a regional non-Sami refer-
ence population [26]. Death from AMI was also 
higher in Sami women but not in female Sami rein-
deer herders [26,27], among whom the incidence of 
AMI was lower and cerebrovascular diseases higher 
[26]. In Finland, no difference in mortality from cer-
ebrovascular disease between Sami and non-Sami 
populations have been reported [28], whereas a lower 
mortality from ischaemic heart disease has been 
observed in Sami women compared to a non-Sami 
female reference population [28,29].
Overall, it seems like Sami men and women may 
have a somewhat increased risk of ischaemic heart 
disease and cerebrovascular disease that does not 
necessarily apply to male reindeer herders, who 
might have reduced risk due to assumed higher phys-
ical activity levels [30]. This seems to contrast with 
what we found in our study, that is, no overall ethnic 
difference in 10-year risk of AMI and cS in men and 
women. We did find that Sami men aged 55–64 years 
had a higher 10-year risk of AMI or cS than their 
non-Sami counterparts. however, this might be a 
chance finding.
The inferior cardiovascular health observed 
among indigenous peoples relative to non-indige-
nous peoples in North America may be due to lower 
socio-economic status and poorer access to quality 
health care among the former [4]. A publication 
from Norway found that differences in smoking hab-
its, systolic blood pressure, serum cholesterol and 
body mass index explained 72% and 56% of the 
absolute and relative educational gradients, respec-
tively, in cVD mortality [31]. Assuming that the 
educational gradient in Sami and non-Sami popula-
tions is the same, the most plausible explanation for 
the similar levels of risk factors and risk of AMI or 
cS observed in our study may be that Sami and 
non-Sami populations in Norway differ little with 
regard to education levels (Tables I and II). however, 
Sjölander et al. found a somewhat higher incidence 
of cerebrovascular diseases and AMI mortality in 
Sami compared to non-Sami women in Sweden, 
which was not explained by education or income 
[26]. Thus, variables other than traditional socio-
economic ones may also be relevant in explaining 
the disparities in the risk of cVD between Sami and 
non-Sami populations. Equal access to health care 
has also been put forward as a plausible explanation 
for the small differences in health and risk factors 
between Sami and non-Sami populations [32]. The 
fact that we observed no difference in anti-hyperten-
sive treatment indicates that ethnic discrepancies in 
access to cVD treatment may not be an issue.
This study has some strengths. The relatively large 
sample of Sami and non-Sami participants from both 
coastal and inland regions, individual information on 
ethnic background and several biological markers 
and clinical measurements enabled an in-depth anal-
ysis of the total risk of AMI or cS. The NORRISK 2 
model has a major advantage, as it takes into account 
competing risk and incorporates both fatal and non-
fatal end points. Furthermore, the NORRISK 2 
model was designed and validated for those aged 
40–79 years in the general population of Norway 
[18], which is the same age range as that included in 
SAMINOR 2.
There are also some limitations. We assumed a 
similar cVD aetiology among Sami and non-Sami 
participants, which may not be correct [15]. 
Moreover, our risk estimations are most likely over-
estimated, as risk factor levels are expected to 
decrease in the future [16]. We did not have data on 
family history of premature ischaemic heart diseases 
and thus could not include it in the model. however, 
unpublished results from the SAMINOR 1 Survey, 
restricted to the same municipalities as SAMINOR 
2, showed no ethnic differences in this regard (results 
not shown). We were not able to assess the 10-year 
risk of AMI or cS among Sami reindeer herders 
alone due to lack of information on occupation and 
association with reindeer husbandry. Finally, the 
NORRISK 2 model does not take into account all 
measured cardiovascular risk factors (e.g. triglycer-
ides, physical activity, waist circumference and diabe-
tes mellitus).
Only 10 municipalities were included in 
SAMINOR 2. Generalisations to the entire Sami or 
non-Sami populations in Norway are therefore not 
justified. Our analyses included 42.7% of the invited 
sample, with more female than male participants, 
though participation in both sexes increased with 
age, as in other studies [33]. Therefore, results for 
the youngest age group, particularly for men, are 
Figure 1. Mean 10-year risk of fatal or non-fatal acute myocardial 
infarction or cerebral stroke by age for non-Sami and Sami men 
(n=2346) and women (n=2972): The SAMINOR 2 clinical Sur-
vey (2012–2014).
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uncertain. We do not know the response rate by eth-
nic group due to lack of ethnic information in 
national registries. however, participation was high-
est in Kautokeino, Nesseby and Tana, where Sami 
are in the majority, and low in some municipalities 
where they are in the minority. This may have led to 
an over-representation of Sami participants from 
majority areas compared to Sami from minority areas 
and non-Sami. Whether this affected the results of 
this study is, however, unknown.
This study provides updated knowledge about the 
cardiovascular health of Sami and non-Sami popula-
tions in rural Northern Norway, which is needed, as 
the majority of comparable studies were conducted 
in Finnmark during 1974–1989. Furthermore, a car-
diovascular risk assessment that combines the impact 
of several risk factors simultaneous and estimates the 
10-year risk of AMI or cS has not been conducted 
previously in Sami and non-Sami populations.
Conclusion
We observed only minor ethnic differences in several 
risk factors for cVDs. Based on results from the 
NORRISK 2 model, we observed no overall differ-
ences in the 10-year risk of AMI or cS between the 
Sami and non-Sami populations living in 10 rural 
municipalities in Northern Norway. Applying the 
thresholds of Selmer et al. [18], 36.4% of men and 
11.6% of women in this population were at high risk 
of AMI or cS.
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